SCHEMBL1824775

SCHEMBL1824775

Cc1c(N)cc(C(C)C)cc1Cc1cc(C(C)C)cc(N)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HIF1A Q16665 2/20 0.41
GAA P10253 2/20 0.41
ALOX12 P18054 1/20 0.41
HTT P42858 1/20 0.41
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP1A2 P05177 2/20 0.40
CASP7 P55210 1/20 0.40
USP2 O75604 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
CYP2D6 P10635 1/20 0.32
FABP3 P05413 1/20 0.31
FABP4 P15090 1/20 0.31
FABP5 Q01469 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
ADRA1D P25100 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11440368 0.88 ALDH1A1 (0.38) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL7169446 0.84 ALDH1A1 (0.48) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL22962176 0.77 ALDH1A1 (0.43) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL9863794 0.77 ALDH1A1 (0.39) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL27494176 0.74 ALDH1A1 (0.55) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL7201559 0.74 ALDH1A1 (0.55) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL9864155 0.74 FABP4 (0.44) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL9863946 0.72 HTT (0.42) ALDH1A1HIF1AGAAALOX12HTT
SCHEMBL9864156 0.71 ALDH1A1 (0.34) ALDH1A1HIF1AGAAALOX15HSD17B10
SCHEMBL10782824 0.71 FABP3 (0.38) ALDH1A1HIF1AGAAALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318450-B1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE HEXCEL COMPOSITES LTD (GB) 2014-02-26 EP disclosed
US-8461275-B2 Curing agents and process for their manufacture Hexcal Composites Limited (GB) 2013-06-11 US disclosed
US-20110130525-A1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE Hexcel Corporation Ltd (GB) 2011-06-02 US disclosed
EP-2318450-A2 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE Hexcel Composites Limited (GB) 2011-05-11 EP disclosed
WO-2010018392-A2 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE HEXCEL COMPOSITES LIMITED (GB) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130525-A1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE ARCN1, PUF60, RCOR1 ALDH1A1 468/4885HIF1A 332/4885GAA 2590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.